Month: September 2008

HPV Assay Enables Major Breakthrough in Diagnosis and Treatment of Head and Neck Cancer

SensiGen LLC has announced a new program to make the Company’s AttoSense HPV assay available to head and neck cancer researchers worldwide after recent studies showed that the success or failure of various treatment options (chemotherapy, radiation, extensive surgery) are largely determined by the viral load of Human Papillomavirus (HPV) in tissue samples from patients.

Read More

New Instrument Examines Multiple Proteins in a Single Cancer Sample

Researchers have demonstrated a new instrument that makes it possible to detect and quantify multiple different clinically important proteins in a single tumor sample using conventional staining. Currently, pathologists usually need a separate tissue slice for each protein they want to examine, making it impossible to see how molecules interact within individual cells.

Read More

AdvanDx Receives FDA 510(k) Clearance for Yeast Traffic Light PNA FISH

AdvanDx announces it has received FDA 510(k) clearance of the Yeast Traffic Light PNA FISH to identify Candida yeast species directly from positive blood cultures. The Yeast Traffic Light is the latest addition to AdvanDx’s easy-to-use, molecular-based PNA FISH diagnostics platform that provides rapid identification of bloodstream pathogens in hours instead of days.

Read More